Nuo Therapeutics, Inc. (AURX)

Market Cap	62.78M +92.5%
Revenue (ttm)	2.61M +123.7%
Net Income	-2.43M
EPS	-0.05
Shares Out	48.29M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,100
Average Volume	5,520
Open	1.350
Previous Close	1.360
Day's Range	1.300 - 1.350
52-Week Range	0.936 - 3.230
Beta	-926.26
RSI	39.77
Earnings Date	Apr 1, 2026

About Nuo Therapeutics

Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. It serves hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The company was formerly known as Cytomedix, Inc. and ch...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9
• Stock Exchange: OTCMKTS
• Ticker Symbol: AURX

Financial Performance

In 2024, Nuo Therapeutics's revenue was $1.37 million, an increase of 124.34% compared to the previous year's $608,525. Losses were -$2.32 million, -26.73% less than in 2023.